Intelicanna Ltd Market Cap ($5.55 Million)
Market Cap & Net Worth: Intelicanna Ltd (INTL)
Intelicanna Ltd market cap. Intelicanna Ltd (TA:INTL) has a market capitalization of $5.55 Million (ILA2.07 Billion) as of November 6, 2026. Listed on the TA stock exchange, this Israel-based company holds position #28283 globally and #405 in its home market, demonstrating a -5.97% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Intelicanna Ltd's stock price ILA44.10 by its total outstanding shares 46957600 (46.96 Million). Also see Intelicanna Ltd cash conversion from operations for how efficiently the company converts equity into cash flow.
Intelicanna Ltd Market Cap History (2015–2026)
Intelicanna Ltd market cap history from 2015 to 2026. Data shows change from $337.75 Million to $5.55 Million (-29.89% CAGR). Check Intelicanna Ltd share price for real-time trading data and today's change.
Intelicanna Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Intelicanna Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset momentum of Intelicanna Ltd to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.01x
Intelicanna Ltd's market cap is 0.01 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.04x
Intelicanna Ltd's market cap is 0.04 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $337.75 Million | $3.01 Billion | $907.90 Million | 0.11x | 0.37x |
| 2016 | $239.04 Million | $3.28 Billion | $1.05 Billion | 0.07x | 0.23x |
| 2017 | $108.27 Million | $3.54 Billion | $1.26 Billion | 0.03x | 0.09x |
| 2018 | $808.22 Million | $3.51 Billion | $1.18 Billion | 0.23x | 0.68x |
| 2019 | $263.11 Million | $3.82 Billion | $1.29 Billion | 0.07x | 0.20x |
| 2020 | $363.70 Million | $2.06 Billion | $95.99 Million | 0.18x | 3.79x |
| 2021 | $109.53 Million | $3.28 Billion | $898.50 Million | 0.03x | 0.12x |
| 2022 | $48.47 Million | $4.07 Billion | $1.22 Billion | 0.01x | 0.04x |
Competitor Companies of INTL by Market Capitalization
Companies near Intelicanna Ltd in the global market cap rankings as of November 6, 2026. Also see INTL asset base for a full breakdown of the balance sheet.
Key companies related to Intelicanna Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #514 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #538 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #588 globally with a market cap of $45.79 Billion USD ( CN¥312.89 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #621 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #514 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #538 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $47.80 |
| #588 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.79 Billion | CN¥49.05 |
| #621 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.50 |
Market Capitalization of Intelicanna Ltd (2015–2026)
Market capitalization of Intelicanna Ltd from 2015 to today. Between 2015 and today, Intelicanna Ltd's market cap moved from $337.75 Million to $ 5.55 Million, with a yearly change of -29.89%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ILA5.55 Million | -54.01% |
| 2025 | ILA12.07 Million | +68.25% |
| 2024 | ILA7.18 Million | -41.54% |
| 2023 | ILA12.27 Million | -74.68% |
| 2022 | ILA48.47 Million | -55.75% |
| 2021 | ILA109.53 Million | -69.89% |
| 2020 | ILA363.70 Million | +38.23% |
| 2019 | ILA263.11 Million | -67.45% |
| 2018 | ILA808.22 Million | +646.51% |
| 2017 | ILA108.27 Million | -54.71% |
| 2016 | ILA239.04 Million | -29.23% |
| 2015 | ILA337.75 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 5th, 2026 the market cap of Intelicanna Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $5.55 Million USD |
| MoneyControl | $5.55 Million USD |
| MarketWatch | $5.55 Million USD |
| marketcap.company | $5.55 Million USD |
| Reuters | $5.55 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Intelicanna Ltd
Intelicanna Ltd operates as pharmaceutical company in Israel. It grows, cultivates, produces, research, markets, and sells medical cannabis. The company was formerly known as Tefen Industrial Engineering & Management & Systems Analysis and changed its name to Intelicanna Ltd in March 2019. The company was founded in 1981 and is headquartered in Hod Hasharon, Israel.